Statistics for BioMarin Pharmaceutical (id:7158 BMRN)

Valuation metrics

Market cap

12.50B

Enterprise value

12.38B

Trailing P/E (ttm)

39.52

Forward P/E

21.94

PEG ratio

21.94

Price/Sales (ttm)

4.54

Price/Book (mrq)

2.31

Enterprise Value/Revenue

4.50

Enterprise Value/EBITDA

29.05

Overview

Shares outstanding

190.58M

Float

179.19M

Shares short

5.38M

% Held by insiders

0.01%

% Held by institutions

1.00%

Average volume (10 days)

1.55M

Average volume (90 days)

Price summary

52-Week low

61.15

52-Week high

99.56

52-Week change

-37.88%

Beta

0.31

50-Day moving average

71.24

200-Day moving average

81.84

Dividends and splits

Forward annual dividend rate

Forward annual dividend yield

Trailing annual dividend rate

0.00%

Trailing annual dividend yield

0.00

5-Year annual dividend yield

Payout ratio

0.00

Dividend date

Ex-dividend date

Last split factor

2:1

Last split date

Financials

Fiscal year

Fiscal year ends

December 31th, 2023

Most recent quarter (mrq)

September 30th, 2024

Profitability

Profit margin

11.71%

Operating margin

15.27%

Operational effectiveness

Return on assets

3.00%

Return on equity

6.25%

Income statement

Revenue (ttm)

14.53

Revenue per share (ttm)

14.53

Quarterly revenue growth (yoy)

1.63

Gross profit (ttm)

1.90B

EBITDA

496.72M

Net income to common (ttm)

322.29M

Diluted EPS (ttm)

1.66

Quarterly earnings growth (yoy)

162.70%

Balance sheet

Total cash (mrq)

930.44M

Total cash per share (mrq)

4.88

Total debt (mrq)

602.69M

Total Debt/Equity (mrq)

11.13

Current ratio (mrq)

427.10%

Book value per share (mrq)

28.41

Cash flow

Cash flow statement

414.70M

Levered free cash flow (LFCF)

144.67M